Statistics

Statistical methods that show up in HEOR work — survival analysis, regression, indirect comparisons, NMAs, Bayesian inference — explained with HTA submissions in mind.

HEOR

Jun 16, 2026

•

3 min read

The 22 missing trials — and where HEOR keeps its own file drawer

Half the antidepressant evidence never reached print, and the same filter sits underneath every SLR, NMA, and cost-effectiveness model. The trick that exposed it works in our field too — if you know where to look for the receipts.

Mirko von Hein

Public Health

Jun 9, 2026

•

3 min read

The Pull Toward the Tail

The prevention paradox says most harm sits in the unremarkable middle. So why does almost every instinct we have drag us toward the severe few, and is that instinct wrong?

Mirko von Hein

Cognitive Bias

May 28, 2026

•

4 min read

The Puppy You Already Named

What the 37% rule really tells pharma about stopping rules, sunk costs, and the behavioural traps in between.

Mirko von Hein

Real-World Evidence

The bombers that didn't come back — and what HEOR can learn from them

May 19, 2026

•

4 min read

The bombers that didn't come back — and what HEOR can learn from them

Five ways survivorship bias shapes results in cost-effectiveness models, NMAs, and real-world comparators

Mirko von Hein

Statistics

The 22 missing trials — and where HEOR keeps its own file drawer

The Pull Toward the Tail

The Puppy You Already Named

The bombers that didn't come back — and what HEOR can learn from them

The HEOR Intel You Actually Need

Tracking what matters in HEOR, market access, and pharma consulting for your career success